ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,720,000 | -36.3% | 342,128 | 0.0% | 0.09% | -51.1% |
| Q1 2019 | $4,273,000 | +16.0% | 342,128 | 0.0% | 0.18% | -35.5% |
| Q4 2018 | $3,685,000 | -65.5% | 342,128 | -55.4% | 0.28% | -3.5% |
| Q3 2018 | $10,694,000 | +13.9% | 767,128 | 0.0% | 0.29% | +78.8% |
| Q2 2018 | $9,390,000 | +43.1% | 767,128 | +80.5% | 0.16% | +37.9% |
| Q1 2018 | $6,562,000 | – | 425,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $40,850,000 | 24.66% |
| Octagon Capital Advisors LP | 2,669,974 | $67,657,000 | 18.06% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,040,000 | 8.36% |
| BVF INC/IL | 3,960,948 | $100,370,000 | 4.85% |
| Finepoint Capital LP | 535,000 | $13,557,000 | 4.69% |
| PFM Health Sciences, LP | 3,346,458 | $84,799,000 | 3.24% |
| ACUTA CAPITAL PARTNERS, LLC | 167,500 | $4,244,000 | 2.36% |
| Boxer Capital, LLC | 1,432,200 | $36,292,000 | 2.30% |
| Parkman Healthcare Partners LLC | 171,214 | $4,339,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 311,782 | $7,901,000 | 1.59% |